Publications

Original Scientific Findings Relating to Q-Cells®
  1. Agatha Lyczek, Antje Arnold, Jiangyang Zhang, James T. Campanelli, Miroslaw Janowski, Jeff W.M. Bulte, Piotr Walczak, Transplanted human glial-restricted progenitors can rescue the survival of dysmyelinated mice independent of the production of mature, compact myelin.  Experimental Neurology, Volume 291, May 2017, Pages 74-86, ISSN 0014-4886

  2. Haas and Fischer (2013) Human astrocytes derived from glial restricted progenitors support regeneration of the injured spinal cord.  J Neurotrauma 30(12): 1035–1052

  3. Kim et al (2012) ICV-Transplanted human glial precursor cells are short-lived yet exert immunomodulatory effects in mice with EAE. Glia 60:117-1129

  4. Lepore et al (2011) Human glial-restricted progenitor transpantation into cervical spinal cord of the SOD1G93A mouse model of ALS. PLoS One 6(10): e25968

  5. Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination. Walczak P, All AH, Rumpal N, Gorelik M, Kim H, Maybhate A, Agrawal G, Campanelli JT, Gilad AA, Kerr DA, Bulte JW. Glia 2011 Mar;59(3):499-510. doi: 10.1002/glia.21119. Epub 2010 Dec 29

  6. Transplantation of Human Glial Restricted Progenitors and Derived Astrocytes into a Contusion Model of Spinal Cord Injury. Jin Y, Neuhuber B, Singh A, Bouyer J, Lepore A, Bonner J, Himes T, Campanelli JT, Fischer I. J Neurotrauma. 2011 Mar 24.

  7. Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders. Sandrock RW, Wheatley W, Levinthal C, Lawson J, Hashimoto B, Rao M, Campanelli JT. Regen Med. 2010 May;5(3):381-94

  8. Lepore et al (2008) Focal tranplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease, Nature Neuroscience, 11 (11): 1294-1301

  9. Windrem et al (2008) Neonatal chimerization with human glial progenitor cells can both remylinate and rescue the otherwise lethally hypomyelinated shiverer mouse, Cell Stem Cell, 2; 553-565

  10. Campanelli et al (2008)  Expression profiling of human glial precursors.  BMC Developmental Biology 8: 102 http://www.biomedicalcentral.com/ 1471-213X/8/102

  11. Lepore et al (2006) Long-term fate of neural precursor cells following transplantation into developing and adult CNS, Neuroscience, 139: 516-530

  12. Kaplin et al (2005) IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis, J. Clinical Investigation, 115 (10): 2731-2741

  13. Lepore et al (2005) Neural precursor cells can be delivered into the injured cervical spinal cord by intrathecal injection at the lumbar cord, Brain Research, 1045: 206 - 216

  14. Mitsui et al (2005) Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity , and modifies intraspinal circuitry, J. Neuroscience, 25(42): 9624-9636

  15. Totoiu et al (2004) Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of Multiple Sclerosis, Exp Neurol, 187: 254-265

  16. Windrem et al (2004) Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain, Nature Medicine, 10(1): 93 - 97

 

Scientific Reviews
 

  1. Krishnan et al (2006) Demyelinating Disorders: Update on Transverse Myelitis, Current Neurology and Neuroscience Reports, 6: 236-243

  2. Frederick & Miller (2006) Future of multiple sclerosis therapy: combining antigen-specific immunotherapy with strategies to promote myelin repair, Future Neurology, 1(4): 489-503

  3. Magnus and Rao (2005) Neural stem cells in inflammatory CNS diseases: mechanisms and therapy, J. Cellular and Molecular Medicine, 9(2): 303-319.

  4. Goldman (2005) Stem and progenitor cell-based therapy of the human central nervous system,Nature Biotechnology, 23(7): 862-871

  5. Krishnan et al (2004) Transverse myelitis: pathogenesis, diagnosis, and treatment, Frontiers in BioScience, 9: 1483-1499

© 2019 Q Therapeutics, Inc.